ArticleFoot & ankle orthopaedics2026
Mid-term Patient-Reported Outcomes Following Isolated Gastrocnemius Recession for Recalcitrant Plantar Fasciitis.
Article in Foot & ankle orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Gastrocnemius Recessions in the Management of Chronic Recalcitrant Plantar Fasciopathy-A Systematic Review.Journal of functional morphology and kinesiology · 2026Review
- Isolated Gastrocnemius Contraction and Gastroc Recession Surgery in Case of Planter Fasciitis: A Systemic Review and Meta-Analysis.Indian journal of orthopaedics · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Most patients with plantar fasciitis experience symptom relief with nonoperative management. However, a subset remains refractory to conservative treatments and may benefit from surgical intervention. Prior studies support the use of isolated gastrocnemius recession, demonstrating favorable short-term outcomes and low complication rates. Herein we assessed the outcomes following an isolated gastrocnemius recession for recalcitrant plantar fasciitis extended to midterm outcomes (36-89 months). Methods: Eighty-eight patients who underwent isolated gastrocnemius recession for recalcitrant plantar fasciitis between September 2014 and June 2017 were identified through procedural codes. Patients were contacted by phone to complete the Foot and Ankle Ability Measure (FAAM) and American Academy of Orthopaedic Surgeons (AAOS) Foot and Ankle Outcomes Questionnaire, and to report satisfaction, willingness to repeat the procedure, and willingness to recommend it. Results: Of 88 eligible patients, 43 completed follow-up (33 females, 10 males) at a mean of 5.0 ± 1.3 years postoperatively. Mean FAAM scores were 92.0 ± 15.0 for activities of daily living and 86.2 ± 24.2 for sports; mean ADL daily function was 91.0% ± 19.8%, with 39 patients reporting normal or near-normal function. Mean AAOS standardized norm-based score was 93.9 ± 11.4, and mean shoe comfort score was 83.5 ± 25.8. Among the 23 patients who provided pain data, mean VAS was 1/10, with 87% rating pain ≤2/10. Overall satisfaction was high: 95% were satisfied, 93% would undergo the procedure again, and 91% would recommend it. One patient required revision gastrocnemius recession with subsequent symptom resolution. Conclusion: Isolated gastrocnemius recession for recalcitrant plantar fasciitis was associated with durable midterm outcomes with high patient satisfaction, substantial functional scores, and low complication rates. These findings support its use in patients who fail conservative management. Level of Evidence: Level IV, therapeutic.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.